|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 13024 |
FusionGeneSummary for FBLN7_ALOXE3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: FBLN7_ALOXE3 | Fusion gene ID: 13024 | Hgene | Tgene | Gene symbol | FBLN7 | ALOXE3 | Gene ID | 129804 | 59344 |
| Gene name | fibulin 7 | arachidonate lipoxygenase 3 | |
| Synonyms | TM14 | ARCI3|E-LOX|eLOX-3|eLOX3 | |
| Cytomap | 2q13-q14.1 | 17p13.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | fibulin-7FIBL-7 | hydroperoxide isomerase ALOXE3Epidermal lipoxygenase-3e-LOX-3epidermal LOX-3epidermal lipoxygenaseepidermis-type lipoxygenase 3hydroperoxy icosatetraenoate dehydratase | |
| Modification date | 20180522 | 20180519 | |
| UniProtAcc | Q53RD9 | Q9BYJ1 | |
| Ensembl transtripts involved in fusion gene | ENST00000331203, ENST00000409903, ENST00000409667, ENST00000409450, ENST00000472377, | ENST00000380149, ENST00000448843, ENST00000318227, | |
| Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 1 X 1 X 1=1 |
| # samples | 2 | 1 | |
| ** MAII score | log2(2/8*10)=1.32192809488736 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: FBLN7 [Title/Abstract] AND ALOXE3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | ALOXE3 | GO:0006665 | sphingolipid metabolic process | 21558561 |
| Tgene | ALOXE3 | GO:0019369 | arachidonic acid metabolic process | 12881489|17045234 |
| Tgene | ALOXE3 | GO:0019372 | lipoxygenase pathway | 20921226 |
| Tgene | ALOXE3 | GO:0043651 | linoleic acid metabolic process | 12881489|17045234 |
| Tgene | ALOXE3 | GO:0051122 | hepoxilin biosynthetic process | 12881489|17045234 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | SARC | TCGA-DX-A6YQ-01A | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000331203 | ENST00000380149 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000331203 | ENST00000448843 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000331203 | ENST00000318227 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000409903 | ENST00000380149 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000409903 | ENST00000448843 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000409903 | ENST00000318227 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000409667 | ENST00000380149 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000409667 | ENST00000448843 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000409667 | ENST00000318227 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000409450 | ENST00000380149 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000409450 | ENST00000448843 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| Frame-shift | ENST00000409450 | ENST00000318227 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| intron-3CDS | ENST00000472377 | ENST00000380149 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| intron-3CDS | ENST00000472377 | ENST00000448843 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
| intron-3CDS | ENST00000472377 | ENST00000318227 | FBLN7 | chr2 | 112942916 | + | ALOXE3 | chr17 | 8012572 | - |
Top |
FusionProtFeatures for FBLN7_ALOXE3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| FBLN7 | ALOXE3 |
| An adhesion molecule that interacts with extracellularmatrix molecules in developing teeth and may play important rolesin differentiation and maintenance of odontoblasts as well as indentin formation. {ECO:0000250}. | Non-heme iron-containing lipoxygenase which is atypicalin that it displays a prominent hydroperoxide isomerase activityand a reduced dioxygenase activity compared to otherlipoxygenases. The hydroperoxide isomerase activity catalyzes theisomerization of hydroperoxides, derived from arachidonic andlinoleic acid by ALOX12B, into hepoxilin-type epoxyalcohols. Thedioxygenase activity requires a step of activation of the enzymeby molecular oxygen. In presence of oxygen, oxygenatespolyunsaturated fatty acids, including arachidonic acid, toproduce fatty acid hydroperoxides. In the skin, acts downstream ofALOX12B on the linoleate moiety of esterified omega-hydroxyacyl-sphingosine (EOS) ceramides to produce an epoxy-ketone derivative,a crucial step in the conjugation of omega-hydroxyceramide tomembrane proteins. Therefore plays a crucial role in the synthesisof corneocytes lipid envelope and the establishment of the skinbarrier to water loss. In parallel, it may have a signalingfunction in barrier formation through the production of hepoxilinsmetabolites. Plays also a role in adipocyte differentiationthrough hepoxilin A3 and hepoxilin B3 production which in turnactivate PPARG. Through the production of hepoxilins in the spinalcord, it may regulate inflammatory tactile allodynia.{ECO:0000269|PubMed:12881489, ECO:0000269|PubMed:17045234,ECO:0000269|PubMed:20921226, ECO:0000269|PubMed:20923767,ECO:0000269|PubMed:21558561}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for FBLN7_ALOXE3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FBLN7_ALOXE3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| FBLN7 | HSPA5, ASPH, TXNDC11, CLNS1A, EDEM2, EGFR | ALOXE3 | C20orf96, ALPK1, GLIPR1, DPPA4, B3GALNT1, PLEKHB2, VEGFB, GLYR1, NBEA, ZFHX4, DNAAF2, SRC, HSPA8, CCDC27, ZSCAN12, EDEM3, MORN3, HOOK1, PVRL2, HERC4, ZIC1, HSPD1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FBLN7_ALOXE3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for FBLN7_ALOXE3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | ALOXE3 | C3539888 | ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3 | 4 | UNIPROT |
| Tgene | ALOXE3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Tgene | ALOXE3 | C0079154 | Congenital Nonbullous Ichthyosiform Erythroderma | 1 | CTD_human;ORPHANET |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|